Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...

The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...

Vepdegestrant (ARV-471) yielded a statistically significant and clinically meaningful improvement in progression-free ...

An Evangelical mission doctor has warned that millions of lives are at stake surrounding the potential dismantling of the U S ...

The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.

Taimed Biologics Inc.’s TMB-365/TMB-380 long-acting combination of broadly neutralizing antibodies (bnAbs) regimen for HIV maintenance could reshape HIV treatment management, offering a viable ...

In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV.